1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
  4. > Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2017

Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2017

Summary

GlobalData’s clinical trial report, “Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2017" provides an overview of Acid Indigestion / Heartburn/ Pyrosis clinical trials scenario. This report provides top line data relating to the clinical trials on Acid Indigestion / Heartburn/ Pyrosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

* Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2017
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Acid Indigestion / Heartburn/ Pyrosis to Gastrointestinal Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Acid Indigestion / Heartburn/ Pyrosis to Gastrointestinal Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Acid Indigestion / Heartburn/ Pyrosis Therapeutics Clinical Trials 27
Prominent Drugs 28
Clinical Trial Profile Snapshots 29
Appendix 102
Abbreviations 102
Definitions 102
Research Methodology 103
Secondary Research 103
About GlobalData 104
Contact Us 104
Disclaimer 104
Source 105

List of Tables
Acid Indigestion / Heartburn/ Pyrosis Therapeutics, Global, Clinical Trials by Region, 2017* 6
Acid Indigestion / Heartburn/ Pyrosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
Acid Indigestion / Heartburn/ Pyrosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8
Acid Indigestion / Heartburn/ Pyrosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 9
Acid Indigestion / Heartburn/ Pyrosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 10
Acid Indigestion / Heartburn/ Pyrosis Therapeutics Clinical Trials, North America, Top Countries, 2017* 11
Acid Indigestion / Heartburn/ Pyrosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 12
Acid Indigestion / Heartburn/ Pyrosis Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 13
Proportion of Acid Indigestion / Heartburn/ Pyrosis to Gastrointestinal Clinical Trials, G7 Countries (%), 2017* 14
Acid Indigestion / Heartburn/ Pyrosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
Acid Indigestion / Heartburn/ Pyrosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
Proportion of Acid Indigestion / Heartburn/ Pyrosis to Gastrointestinal Clinical Trials, E7 Countries (%), 2017* 17
Acid Indigestion / Heartburn/ Pyrosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 18
Acid Indigestion / Heartburn/ Pyrosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 19
Acid Indigestion / Heartburn/ Pyrosis Therapeutics, Global, Clinical Trials by Phase, 2017* 20
Acid Indigestion / Heartburn/ Pyrosis Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 21
Acid Indigestion / Heartburn/ Pyrosis Therapeutics, Global, Clinical Trials by Trial Status, 2017* 22
Acid Indigestion / Heartburn/ Pyrosis Therapeutics Clinical Trials, Global, by End Point Status, 2017* 23
Acid Indigestion / Heartburn/ Pyrosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 24
Acid Indigestion / Heartburn/ Pyrosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 25
Acid Indigestion / Heartburn/ Pyrosis Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 26
Acid Indigestion / Heartburn/ Pyrosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 27
Acid Indigestion / Heartburn/ Pyrosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 28

List of Figures
Acid Indigestion / Heartburn/ Pyrosis Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
Acid Indigestion / Heartburn/ Pyrosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
Acid Indigestion / Heartburn/ Pyrosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8
Acid Indigestion / Heartburn/ Pyrosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 9
Acid Indigestion / Heartburn/ Pyrosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 10
Acid Indigestion / Heartburn/ Pyrosis Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 11
Acid Indigestion / Heartburn/ Pyrosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 12
Proportion of Acid Indigestion / Heartburn/ Pyrosis to Gastrointestinal Clinical Trials, G7 Countries (%), 2017* 14
Acid Indigestion / Heartburn/ Pyrosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
Acid Indigestion / Heartburn/ Pyrosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
Proportion of Acid Indigestion / Heartburn/ Pyrosis to Gastrointestinal Clinical Trials, E7 Countries (%), 2017* 17
Acid Indigestion / Heartburn/ Pyrosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 18
Acid Indigestion / Heartburn/ Pyrosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 19
Acid Indigestion / Heartburn/ Pyrosis Therapeutics, Global, Clinical Trials by Phase (%), 2017* 20
Acid Indigestion / Heartburn/ Pyrosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 21
Acid Indigestion / Heartburn/ Pyrosis Therapeutics, Global, Clinical Trials by Trial Status, 2017* 22
Acid Indigestion / Heartburn/ Pyrosis Therapeutics Clinical Trials, Global, by End Point Status, 2017* 23
Acid Indigestion / Heartburn/ Pyrosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 24
Acid Indigestion / Heartburn/ Pyrosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 25
Acid Indigestion / Heartburn/ Pyrosis Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 26
Acid Indigestion / Heartburn/ Pyrosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 27
Acid Indigestion / Heartburn/ Pyrosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 28
GlobalData Methodology 103

Companies Mentioned
AstraZeneca Plc
Takeda Pharmaceutical Company Ltd
Novartis AG
Reckitt Benckiser Group Plc
Johnson and Johnson
Eisai Co Ltd
Dr. Reddy's Laboratories Ltd
ELPEN Pharmaceutical Co Inc
Dexcel PT Holdings Ltd
Bayer AG

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Epiomic Epidemiology Series: Irritable Bowel Syndrome Forecast in 12 Major Markets 2017-2027

Epiomic Epidemiology Series: Irritable Bowel Syndrome Forecast in 12 Major Markets 2017-2027

  • $ 5112
  • Industry report
  • February 2017
  • by Black Swan Analysis Ltd

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Irritable Bowel Syndrome in 12 Major Markets Irritable Bowel Syndrome (IBS) is a functional bowel disorder which incorporates a group ...

Gastroesophageal Reflux Disease (GERD)  - Market Insights, Epidemiology and Market Forecast-2023

Gastroesophageal Reflux Disease (GERD)  - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s Gastroesophageal Reflux Disease (GERD) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Gastroesophageal ...

Irritable Bowel Syndrome - Market Insights, Epidemiology and Market Forecast-2023

Irritable Bowel Syndrome - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • March 2017
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Irritable Bowel Syndrome - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease ...


Download Unlimited Documents from Trusted Public Sources

Gastrointestinal Drug Industry in Canada

  • March 2017
    92 pages
  • Gastrointestina...  

    Health Care Pro...  

    Ambulatory Care  

  • Canada  

    North America  

View report >

Gastrointestinal Drug Industry in Canada

  • March 2017
    92 pages
  • Gastrointestina...  

    Health Care Pro...  

    Ambulatory Care  

  • Canada  

    North America  

View report >

Gastrointestinal Drug Industry in the US - Forecast

  • January 2017
    4 pages
  • Gastrointestina...  

    Digestive Syste...  

    Hormone  

  • United States  

View report >

Related Market Segments :

Gastrointestinal Drug
Clinical Trial

ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.